USTEKINUMAB

ustekinumab 130 mg/26 mL injection, 26 mL vial

USTEKINUMAB (11164N)

ustekinumab 130 mg/26 mL injection, 26 mL vial
11164N
Body System:
Manner of administration:Injection
Private
S100 HSD Private
Authority Required

Restriction

Indication: Severe Crohn disease
Treatment phase: Initial 1 (new patient)

Restriction

Indication: Severe Crohn disease
Treatment phase: Initial 2 (change or recommencement of treatment after a break in targeted therapy of less than 12 months)

Restriction

Indication: Severe Crohn disease
Treatment phase: Initial 3 (recommencement of treatment after a break in targeted therapy of more than 12 months)
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 4 Max qty units: 4 # of repeats: 0 DPMQ: $2,292.16 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Stelara
Steqeyma
Wezlana